Unigen, Inc.
Shengxin Cai is a Research Scientist I/II at Unigen, Inc., since January 2020, specializing in fast-paced CRO projects, including the design of experiments, proposal development, communication, and reporting, as well as LCMS-guided bioactive compound purification and characterization from medicinal plants. Prior to this role, Shengxin Cai served as a Research Assistant Professor and Postdoctoral Research Associate at the University of Oklahoma from February 2012 to December 2019, focusing on bioactive small molecules from fungi and plants, managing a pure compound library, and collaborating on bioassay screening. Shengxin Cai earned a Ph.D. in Medicinal Chemistry from Ocean University of China in 2011, following a B.S. in Pharmaceutical Sciences from the same institution in 2006.
This person is not in any teams
This person is not in any offices
Unigen, Inc.
1 followers
From discovery to distribution, Unigen is dedicated to the development of botanical and marine-derived therapeutic compounds that address consumer health needs and improve quality of life. Established in 1996, our research and discovery process includes extensive testing at the genetic, cellular, and human clinical levels. Unigen is a global leader in the discovery and development of proprietary natural ingredients for the dietary supplement, food, cosmetics, personal care and pharmaceutical industries. With a core of scientifically substantiated natural ingredients already distribute worldwide, we continue to push the boundaries of pharmaceutical quality research and novel applications for natural products. The company has one of the most extensive medicinal plant collections in the world and utilizes a state-of-the-art pharmaceutical discovery approach to identify the most safe and effective botanically-based proprietary ingredients. The efficacy of Unigen’s natural product ingredients is established through human clinical trials, and unlike synthetic drugs, Unigen’s natural substances have a legacy of safe human consumption without the undesirable side-effects that limit the use of pharmaceuticals. Unigen protects its discoveries through patents and commercializes its products through alliances with partners that possess distribution and marketing capabilities in each of Unigen’s target markets.